Kevin J. Ontiveros
Nessuna posizione attualmente
Profilo
Kevin J.
Ontiveros served as Vice President-Corporate Law & Assistant Secretary at NPS Pharmaceuticals, Inc. from 1996 to 2007.
He then worked as Secretary, VP-Legal Affairs & General Counsel at ImaRx Therapeutics, Inc. He later served as Secretary, Chief Legal & Compliance Officer at SINTX Technologies, Inc. from 2013 to 2015.
Ontiveros received his undergraduate degree from the University of Arizona, his graduate degree from the University of Florida, and his law degree from S.J.
Quinney College of Law.
Precedenti posizioni note di Kevin J. Ontiveros
| Società | Posizione | Fine |
|---|---|---|
| SINTX TECHNOLOGIES, INC. | Responsabile della Conformità | 08/01/2015 |
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Consigliere Generale | 11/06/2008 |
| NPS PHARMACEUTICALS, INC. | Consigliere Generale | - |
Formazione di Kevin J. Ontiveros
| University of Florida | Graduate Degree |
| University of Arizona | Undergraduate Degree |
| S.J. Quinney College of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SINTX TECHNOLOGIES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
- Borsa valori
- Insiders
- Kevin J. Ontiveros
